HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: Involvement of L-arginine/nitric oxide pathway.

Abstract
After nearly 60years, lithium is still the mainstay in the treatment of mood disorders. In addition to its antimanic and antidepressant effects, lithium also has anticonvulsant properties. Similar to lithium, agmatine plays a protective role in the central nervous system against seizures and has been reported to enhance the effect of different antiepileptic agents. Moreover, both agmatine and lithium have modulatory effects on the L-arginine/nitric oxide pathway. This study was designed to investigate: (1) whether agmatine and lithium exert a synergistic effect against clonic seizures induced by pentylenetetrazole and (2) whether or not this synergistic effect is mediated through inhibition of the L-arginine/nitric oxide pathway. In our study, acute administration of a single potent dose of lithium chloride (30mg/kg ip) increased seizure threshold, whereas pretreatment with a low and independently noneffective dose of agmatine (3mg/kg) potentiated a subeffective dose of lithium (10mg/kg). N(G)-L-arginine methyl ester (L-NAME, nonspecific nitric oxide synthase inhibitor) at 1 and 5mg/kg and 7-nitroindazole (7-NI, preferential neuronal nitric oxide synthase inhibitor) at 15 and 30mg/kg augmented the anticonvulsant effect of the noneffective combination of lithium (10mg/kg ip) and agmatine (1mg/kg), whereas several doses (20 and 40mg/kg) of aminoguanidine (inducible nitric oxide synthase inhibitor) failed to alter the seizure threshold of the same combination. Furthermore, pretreatment with independently noneffective doses (30 and 60mg/kg) of L-arginine (substrate for nitric oxide synthase) inhibited the potentiating effect of agmatine (3mg/kg) on lithium (10mg/kg). Our findings demonstrate that agmatine and lithium chloride have synergistic anticonvulsant properties that may be mediated through the L-arginine/nitric oxide pathway. In addition, the role of constitutive nitric oxide synthase versus inducible nitric oxide synthase is prominent in this phenomenon.
AuthorsArash Bahremand, Pouya Ziai, Tina Kabiri Khodadad, Borna Payandemehr, Reza Rahimian, Abbas Ghasemi, Mehdi Ghasemi, Tina Hedayat, Ahmad Reza Dehpour
JournalEpilepsy & behavior : E&B (Epilepsy Behav) Vol. 18 Issue 3 Pg. 186-92 (Jul 2010) ISSN: 1525-5069 [Electronic] United States
PMID20493779 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Antidepressive Agents
  • Enzyme Inhibitors
  • Indazoles
  • Nitric Oxide
  • Agmatine
  • Arginine
  • Lithium Chloride
  • 7-nitroindazole
  • NG-Nitroarginine Methyl Ester
  • Pentylenetetrazole
Topics
  • Agmatine (therapeutic use)
  • Analysis of Variance
  • Animals
  • Antidepressive Agents (therapeutic use)
  • Arginine (metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Enzyme Inhibitors (pharmacology)
  • Indazoles (pharmacology)
  • Lithium Chloride (therapeutic use)
  • Male
  • Mice
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Nitric Oxide (metabolism)
  • Pentylenetetrazole
  • Seizures (chemically induced, drug therapy, metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: